pharmacie et médicaments – Division par deux du plafond des remises commerciales sur les génériques

This written question concerns proposed changes to the commercial rebate caps for generic medicines in France. It questions the rationale and potential impact of halving these caps. The measure could affect pharmaceutical companies, pharmacies, and potentially the cost and availability of generic drugs for patients.